Jersey’s regulated cannabis industry is becoming increasingly focused on international markets, with new government data showing a major rise in the number of cannabis export licences approved during 2025.
According to figures released through a Freedom of Information request, Jersey’s Office of the Chief Pharmacist approved 167 cannabis export licences in 2025.
This was significantly higher than the 87 export licences approved in 2024 and the 26 licences recorded in 2023.
2023: 26 licences
2024: 87 licences
2025: 167 licences
The latest figures mean the number of cannabis export licences approved by Jersey increased by approximately 92% between 2024 and 2025.
Cannabis Imports Declined
While cannabis exports increased, the number of import licences approved by the island declined.
Jersey approved a total of 216 cannabis import licences in 2025, including personal and commercial imports.
This was lower than the 228 import licences approved in 2024 and the 286 licences recorded in 2023.
2023: 286 licences
2024: 228 licences
2025: 216 licences
However, these figures only show the number of licences approved. They do not reveal the actual weight, value or total volume of cannabis imported or exported under each licence.
Northern Leaf Credits Faster Licence Approvals
Northern Leaf, a Jersey-based producer of medicinal cannabis products, said the island’s efficient licensing process had helped support the growth of cannabis exports.
Northern Leaf chief executive Steven Tan said the company exports all the cannabis products it produces in Jersey.
According to Tan, export licences are normally approved by the Jersey government within approximately 48 hours.
“This gives companies like Northern Leaf the speed and certainty needed to respond to customer demand, maintain reliable supply chains and help medicines reach patients across the UK and Europe without unnecessary delays.”
Why Faster Approvals Matter
International medicinal cannabis shipments usually require export permits, import permissions, pharmaceutical documentation, customs clearance and compliance with strict quality standards.
Delays in any part of the process can disrupt supply chains and make it more difficult for pharmacies, distributors and healthcare providers to maintain reliable access to cannabis-based medicines.
Jersey’s relatively fast approval process could therefore give licensed producers operating on the island an advantage when supplying customers across the United Kingdom and Europe.
Jersey’s Growing Medicinal Cannabis Industry
Jersey has traditionally been associated with agriculture, tourism and financial services. However, medicinal cannabis is now emerging as another specialised industry with international potential.
The sharp increase in export licences suggests that regulated cannabis trading activity is becoming more frequent, even though the data does not confirm how much cannabis was shipped under those licences.
The decline in import approvals, combined with the rise in exports, may also indicate that Jersey’s cannabis sector is becoming more focused on local cultivation and international distribution.
Future data showing the actual quantity of cannabis exported, its value and its destination markets would provide a clearer picture of the industry’s economic growth.
.jpg)
0 Comments
Hi write down your query.